Brian T. Dorsey's most recent trade in ARS Pharmaceuticals Inc was a trade of 261,900 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 261,900 | 261,900 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Brian Dorsey T. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 25,000 | 21,828 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Dorsey Brian T. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 11 Dec 2024 | 25,000 | 31,024 | - | 0.6 | 16,000 | Common Stock |
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 11 Dec 2024 | 25,000 | 6,024 | - | 12.3 | 307,433 | Common Stock |
| ARS Pharmaceuticals Inc | Dorsey Brian T. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 11 Dec 2024 | 15,000 | 21,024 | - | 0.6 | 9,600 | Common Stock |
| ARS Pharmaceuticals Inc | Brian Dorsey T. | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 11 Dec 2024 | 15,000 | 6,024 | - | 12.4 | 186,426 | Common Stock |
| ARS Pharmaceuticals Inc | Brian Dorsey T. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 15,000 | 46,828 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 20 Aug 2024 | 50,000 | 6,024 | - | 15 | 750,000 | Common Stock |
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 20 Aug 2024 | 50,000 | 56,024 | - | 0.6 | 32,000 | Common Stock |
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 50,000 | 61,828 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 13 Aug 2024 | 30,000 | 36,024 | - | 0.6 | 19,200 | Common Stock |
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 30,000 | 111,828 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 13 Aug 2024 | 30,000 | 6,024 | - | 13 | 390,000 | Common Stock |
| ARS Pharmaceuticals Inc | Dorsey Brian T. | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 350,000 | 350,000 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Brian T. Dorsey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 145,000 | 145,000 | - | - | Stock option (right to buy) |